Search Results for: GLOBAL REPORT 2017 Global Drug
Articles
PRODRUG TECHNOLOGY - Prodrugs for ADHD Treatments: Opportunities & Potential to Fill Unmet Medical Needs March 4, 2019
Travis Mickle, PhD, indicates key properties that prodrugs can potentially modify generally fall within one or more of the ADME categories, with the goal being the creation of an NCE that optimizes the performance, utility, and potential life-cycle management of the parent drug.
GLOBAL REPORT - 2018 Global Drug Delivery & Formulation Report: Part 1, a Global Review March 1, 2019
In part 1 of this 4-part series, PharmaCircle, in collaboration with Drug Development & Delivery, focuses on a global review of 2018 product approvals.
SPECIAL FEATURE - Outsourcing Analytical Testing: The Gateway to Drug Manufacturing January 10, 2019
Contributor Cindy H. Dubin speaks with several leading analytical labs and CDMOs to review their technologies, services, and new strategies to operate in this ever-changing environment.
Orphazyme Reports Encouraging Arimoclomol Clinical Trial Top-Line Data October 8, 2018
Orphazyme A/S recently announced encouraging top-line results for its clinical Phase II/III trial with orally administered arimoclomol for the treatment...ARTIFICIAL INTELLIGENCE - 3Ds Powering AI in Drug Discovery – Domain Expertise, Deep Learning & Data October 2, 2018
Liran Belenzon and Simon Smith counter skepticism about AI with concrete data on recent exponential progress, provide examples of companies applying these advances to drug discovery, and show how those combining domain expertise, deep learning, and proprietary data are excelling.
BUCCAL FILMS - Better Drug Release & Patient Experiences With Buccal Films October 2, 2018
Robert Davidson and Jessica Rousset explain how buccal administration further represents a better alternative to injections or tablets for those patients who have difficulty swallowing.
MARKET BRIEF - Alzheimer’s Disease Market Report (2016-2026) October 2, 2018
Akiko Fukui, MSc, indicates that amid several failures, the AD pipeline is large and consists of many novel mechanisms, which makes it an exciting market undergoing rapid changes despite its high risk.
Metrion Biosciences & AMRI Collaborate to Offer Ion Channel Drug Discovery Services September 5, 2018
Metrion Biosciences Limited and AMRI recently announced they have signed a new collaboration agreement. The alliance will promote Metrion’s electrophysiology and ion channel screening expertise to global pharmaceutical and biotechnology clients.
SPECIAL FEATURE - Injection Devices: As Self-Injection Grows, Drug Delivery Gets Smarter August 28, 2018
Contributor Cindy H. Dubin reviews some of the innovative and novel technologies developers are deploying to make self-injection easier and improve patient adherence.
Boehringer Ingelheim & OSE Immunotherapeutics Announce Global Immuno-Oncology Partnership April 4, 2018
Boehringer Ingelheim and OSE Immunotherapeutics recently announced a collaboration and exclusive worldwide collaboration and license agreement to jointly develop OSE-172,...FDA UPDATE - The FDA's New Drug Approval Process: Development & Premarket Applications April 2, 2018
Kaiser J. Aziz, PhD, in this latest FDA update, emphasizes quality system approaches to the development and availability of new drug information presented in the proposed labeling of the product.
Idera Pharmaceuticals Announces Launch of Global Phase 3 Trial March 6, 2018
Idera Pharmaceuticals, Inc. recently announced the start of a Phase 3 global, multi-center, open-label clinical trial to evaluate the efficacy...Sarepta Therapeutics Signs Exclusive Global Collaboration November 6, 2017
Sarepta Therapeutics, Inc. recently announced it has signed a research collaboration agreement with Duke University, granting the company an option...SPECIAL FEATURE - Injectable Drug Delivery: New Technologies Deliver Biologics & Differentiate Brands September 12, 2017
Contributor Cindy H. Dubin reports on a segment of the drug delivery industry that will see its market revenue double in just 5 years in response to a growing need to deliver highly viscous, high-volume drugs.